WZ
Wenwu Zhai, MD, PhD
Chief Scientific Officer (CSO) / R&D General Manager
HanchorBioHanchorBio Pipeline
| Drug | Indication | Phase |
|---|
| HCB101 | Gastric Cancer (HER2+), HNSCC, CRC, TNBC, SCLC | Phase 1b/2a |
| HCB301 | Solid Tumors, Hematologic Malignancies | Phase 1 |
| HCB303 | Solid Tumors, Hematologic Malignancies | Preclinical |
| HCB206 | Autoimmune Diseases | Preclinical |